PM012 Tablet
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PM012 Tablet, covering 2023-04-18 to 2023-04-18. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Clinical Study to Explore the Optimal Dosage/Administration of PM012 Tablet in Alzheimer's Disease [Phase 2, Phase 3]